Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first ...

Experts with the Cleveland Clinic say the drug has a lot of potential, especially since it is considered nonaddictive.

The drug offers a non-addictive alternative to opioids, marking 'an important public health milestone in acute pain ...

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

A recent study highlights the effectiveness of Pain Coping Skills Training (PCST) in reducing chronic pain among dialysis patients. The study, involving 643 participants, shows how non-opioid ...

All three cannabinoids reduced the electrical activity linked to Nav1.8, but CBG had the strongest effect. This suggests that CBG could be the most promising candidate for developing new pain ...

People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it ...

A new drug approved Thursday by the FDA offers pain management but is not addictive. Unlike opioids, it treats pain signals ...

Uber says it's being taken for a ride by a network of law firms, doctors, and pain-management clinics in New York, accusing them of orchestrating fraudulen ...

On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...

The FDA recently approved Vertex Pharmaceuticals Incorporated’s Journavx (suzetrigine), a first-in-class non-opioid ...